Vancouver, Canada

Arpita Maiti

This inventor holds 2 USPTO granted patents and 5 published patent applications and 3 EPO patents. Top assignee: Angiotech International Ag. Active years: 2007-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arpita Maiti. Retrieved from https://idiyas.com/inventor/arpita-maiti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 332(Granted Patents)


Company Filing History:


Years Active: 2007-2016

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Arpita Maiti: Innovator in Drug Delivery Systems

Introduction

Arpita Maiti is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of drug delivery systems, holding two patents that showcase her innovative approach to medical applications. Her work focuses on developing compositions that enhance the effectiveness of drug delivery in various tissue-related applications.

Latest Patents

One of Arpita Maiti's latest patents is centered around a drug delivery system utilizing a rapid gelling polymer composition. This invention involves compositions that form covalent linkages when mixed, making them particularly suitable for applications requiring quick adhesion to tissue and gel formation. These compositions serve multiple purposes, including tissue sealants, promoting hemostasis, facilitating tissue adhesion, providing tissue augmentation, and preventing surgical adhesions. Another notable patent involves the use of medical implants in combination with fibrosis-inducing agents. This innovation aims to induce fibrosis that may not naturally occur when an implant is placed within an animal, thereby enhancing the integration of the implant with host tissue.

Career Highlights

Arpita Maiti is currently associated with Angiotech International Ag, where she continues to advance her research and development efforts in the medical field. Her work has garnered attention for its potential to improve patient outcomes through innovative drug delivery methods.

Collaborations

Throughout her career, Arpita has collaborated with esteemed colleagues, including David

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…